With the International Society for Stem Cell Research’s Annual Meeting as his backdrop, Dr. Saud A. Sadiq delivered more promising results from Tisch MS Research Center of New York’s (Tisch MSRCNY) FDA-approved Phase I stem cell trial. The global event, which serves as the voice of the stem cell community, attracted over 3,500 participants who foster and exchange important dialogue...